FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Media coverage

• Title	FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	9/04/25
  URL	ct.moreover.com/?a=56449859557&p=1gw&v=1&x=PVaTFFkXxfuD-auCKPaDWQ
  Persons	Kevin Chung